Fig. 1From: Stereotactic body radiotherapy versus lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity matching score analysisFlow chart of the study design. SBRT, stereotactic body radiotherapy. PSM, propensity score matchingBack to article page